Literature DB >> 29878174

The trials of neuro-oncology clinical research.

Lisa M DeAngelis1.   

Abstract

Mesh：

Year:  2018        PMID： 29878174      PMCID： PMC6280135          DOI： 10.1093/neuonc/noy076

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  8 in total

Review 1.  The significance of the trial outcome was associated with publication rate and time to publication.

Authors:  Seung Yeon Song; Dong-Hoe Koo; Sun-Young Jung; Wonku Kang; Eun Young Kim
Journal:  J Clin Epidemiol       Date:  2017-02-24       Impact factor: 6.437

2.  The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?

Authors:  Alyssa M Vanderbeek; Rifaquat Rahman; Geoffrey Fell; Steffen Ventz; Tianqi Chen; Robert Redd; Giovanni Parmigiani; Timothy F Cloughesy; Patrick Y Wen; Lorenzo Trippa; Brian M Alexander
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

3.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Authors:  M D Walker; E Alexander; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; H A Norrell; G Owens; J Ransohoff; C B Wilson; E A Gehan; T A Strike
Journal:  J Neurosurg       Date:  1978-09       Impact factor: 5.115

4.  Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic.

Authors:  Lydia T Madsen; Deborah A Kuban; Seungtaek Choi; John W Davis; Jeri Kim; Andrew K Lee; Delora Domain; Larry Levy; Louis L Pisters; Curtis A Pettaway; John F Ward; Christopher Logothetis; Karen E Hoffman
Journal:  J Natl Compr Canc Netw       Date:  2014-07       Impact factor: 11.908

5.  Selection bias, survival, and brachytherapy for glioma.

Authors:  R C Florell; D R Macdonald; W D Irish; M Bernstein; S A Leibel; P H Gutin; J G Cairncross
Journal:  J Neurosurg       Date:  1992-02       Impact factor: 5.115

6.  Evaluating glioma therapies: modeling treatments and predicting outcomes.

Authors:  S Kirby; M Brothers; W Irish; R Florell; D Macdonald; C Schold; G Cairncross
Journal:  J Natl Cancer Inst       Date:  1995-12-20       Impact factor: 13.506

7.  Preclinical efficacy studies in investigator brochures: Do they enable risk-benefit assessment?

Authors:  Susanne Wieschowski; William Wei Lim Chin; Carole Federico; Sören Sievers; Jonathan Kimmelman; Daniel Strech
Journal:  PLoS Biol       Date:  2018-04-05       Impact factor: 8.029

8.  Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?

Authors:  Alessandro Ottaiano; Antonino Cassata; Monica Capozzi; Chiara De Divitiis; Alfonso De Stefano; Antonio Avallone
Journal:  Front Oncol       Date:  2018-03-14       Impact factor: 6.244
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.